Home/Filings/4/0001140361-24-009273
4//SEC Filing

Sestrick Michael Robert 4

Accession 0001140361-24-009273

CIK 0000009326other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:41 PM ET

Size

15.6 KB

Accession

0001140361-24-009273

Insider Transaction Report

Form 4
Period: 2024-02-21
Sestrick Michael Robert
SVP & Chief Technology Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-02-21$76.89/sh+3,900$299,87110,636 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-02-213,5000 total
    Exercise: $74.57Exp: 2028-02-15Common Stock (3,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-21$84.09/sh+3,700$311,13317,836 total
  • Exercise/Conversion

    Common Stock

    2024-02-21$74.57/sh+3,500$260,99514,136 total
  • Sale

    Common Stock

    2024-02-21$153.21/sh11,100$1,700,6136,736 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-02-213,9000 total
    Exercise: $76.89Exp: 2027-04-18Common Stock (3,900 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-02-213,7000 total
    Exercise: $84.09Exp: 2029-02-13Common Stock (3,700 underlying)
Footnotes (5)
  • [F1]Exercise of fully vested non-qualified stock options.
  • [F2]This transaction was executed in multiple sales ranging from $152.7200 to $153.6600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F3]Stock options that vested 20% on April 18, 2018, 40% on April 18, 2019, and 40% on April 18, 2020, and are exercisable.
  • [F4]Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
  • [F5]Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001906436

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:41 PM ET
Size
15.6 KB